NTRB Nutriband
- 3.360
- -0.010-0.30%
Nutriband News
Nutriband Announced That Following Its Engagement By Fit For Life (FFL) Group On April 19, 2024, The Companies Fully Executed An Exclusive Supplier Agreement For FFL's New Product Launch Under One Of Their Top Brands
Nutriband Announced That Following Its Engagement By Fit For Life (FFL) Group On April 19, 2024, The Companies Fully Executed An Exclusive Supplier Agreement For FFL's New Product Launch Under One Of
Nutriband Signs Exclusive Supplier Agreement With Fit for Life
Precision Biosciences, Mesoblast, Pulse Biosciences Among Healthcare Movers
Nutriband Inc. Begins Manufacturing for Major Sports Brand Licensee Fit for Life Group, Whose Collection of Partnered Brands Include Reebok, Adidas and New Balance
ORLANDO, FL / ACCESSWIRE / April 1, 2024 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a pharmaceutical company with a specific focus on transdermal technologies, today announces it has been engaged b
KOD, ALLG and SST Among Mid-day Movers
Nutriband Shares Rise 30% After Fentanyl Patch Partnership News, Planned FDA Submission
By Stephen Nakrosis Shares of Nutriband were trading higher after the company said it partnered with Kindeva Drug Delivery to develop a transdermal fentanyl patch system. Nutriband shares were tradi
IBio, ImmunityBio, Mesoblast Among Healthcare Movers
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
GainersLixte Biotechnology (NASDAQ:LIXT) shares moved upwards by 67.2% to $3.77 during Wednesday's pre-market session. The market value of their outstanding shares is at $8.4 million. Nutriband (NASDA
Nutriband Provides Clinical and Regulatory Path Overview for Lead Product - AVERSA(R) Fentanyl Transdermal Patch
NDA will be primarily based on a single Phase 1 human abuse potential clinical study with no Phase 2 or 3 clinical trials needed prior to submission.AVERSA Fentanyl incorporates Nutriband's Aversa abu
12 Health Care Stocks Moving In Friday's After-Market Session
GainersSalarius Pharmaceuticals (NASDAQ:SLRX) shares rose 33.9% to $0.83 during Friday's after-market session. The market value of their outstanding shares is at $3.2 million. Masimo (NASDAQ:MASI) sha
12 Health Care Stocks Moving In Friday's Pre-Market Session
GainersBiolase (NASDAQ:BIOL) shares moved upwards by 61.5% to $0.24 during Friday's pre-market session. The market value of their outstanding shares is at $4.6 million. The company's, Q4 earnings came
Nutriband Inc. to Present at The Microcap Conference Atlantic City January 30th Through February 1st
Nutriband Inc. to Present at The Microcap Conference Atlantic City January 30th through February 1st.ORLANDO, FL / ACCESSWIRE / January 29, 2024 / Nutriband Inc. today announced that it will
Nutriband CEO Publishes Letter to Shareholders
ORLANDO, FL / ACCESSWIRE / January 26, 2024 / Nutriband Inc. today announced that CEO Gareth Sheridan has published a letter to shareholders providing insights on
Nutriband Inc Shareholders Approve Key Corporate Resolutions
Nutriband Partners With Kindeva for Fentanyl Patch Development
Nutriband Inc. Expands Its AI Kinesiology Tape Portfolio With the Launch of AI Tape Heating and Cooling
ORLANDO, FL / ACCESSWIRE / November 28, 2023 / Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW), a developer of transdermal pharmaceutical products, today announced the launch of its new Heating and Coolin
Nutriband Inc. Signs Supplier Agreement With KT Tape, the World Leader in Kinesiology Tape
ORLANDO, FL / ACCESSWIRE / November 8, 2023 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), today announced that it has signed a supplier agreement with market leading kinesiology tape company, KT Tape.
Top Premarket Decliners
Ventyx Biosciences (VTYX) shares fell 75% Tuesday premarket after the company said late Monday that a phase 2 trial of its plaque psoriasis treatment failed to meet its efficacy target. Nutriband (NTR
Nutriband GAAP EPS of -$0.11
Nutriband (NTRB.US): The 2023 Q2 financial report achieved revenue of US$655.93 million, the previous value was US$456.15 million; earnings per share was -0.11 dollars, and the previous value was -0.12 dollars.
Nutriband (NTRB.US): The 2023 Q2 financial report achieved revenue of US$655.93 million, the previous value was US$456.15 million; earnings per share was -0.11 dollars, and the previous value was -0.12 dollars.
Analysis
Price Target
No Data
